Real-time
Other stock markets
|
|
5-day change | 1st Jan Change | |
15.57 EUR | -1.02% | +0.71% | +30.62% |
Nov. 02 | Bank of America starts Unite Group with 'buy' | AN |
Nov. 01 | FTSE 100 Closes Up 0.28% as Interest Rate Rise Fears Start to Ease | DJ |
Sales 2023 * | 5.17B 5.58B | Sales 2024 * | 5.37B 5.79B | Capitalization | 4.14B 4.47B |
---|---|---|---|---|---|
Net income 2023 * | 307M 331M | Net income 2024 * | 285M 307M | EV / Sales 2023 * | 0,87x |
Net Debt 2023 * | 347M 374M | Net Debt 2024 * | 123M 133M | EV / Sales 2024 * | 0,79x |
P/E ratio 2023 * | 14,3x | P/E ratio 2024 * | 14,7x | Employees | 6,163 |
Yield 2023 * | 2,19% | Yield 2024 * | 2,33% | Free-Float | 70.29% |
More Fundamentals
* Assessed data
More news
More news
1 day | +0.64% | ||
1 week | +1.81% | ||
Current month | +1.61% | ||
1 month | +0.25% | ||
3 months | +3.90% | ||
6 months | +15.66% | ||
Current year | +31.96% |
1 week
15.47
15.94

1 month
15.13
15.94

Current year
11.01
16.04

1 year
11.01
16.04

3 years
9.71
16.04

5 years
7.44
19.38

10 years
7.44
19.60

Managers | Title | Age | Since |
---|---|---|---|
Siobhán Talbot
CEO | Chief Executive Officer | 59 | 2009 |
Mark Garvey
DFI | Director of Finance/CFO | 59 | 2013 |
Liam Hennigan
IRC | Investor Relations Contact | - | 2014 |
Members of the board | Title | Age | Since |
---|---|---|---|
Siobhán Talbot
CEO | Chief Executive Officer | 59 | 2009 |
Daniel O'Connor
BRD | Director/Board Member | 62 | 2014 |
Jane Lodge
BRD | Director/Board Member | 67 | 2020 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.37% | 83 M€ | +25.22% | ||
2.17% | 9 M€ | +7.34% | ||
1.94% | 1,037 M€ | +11.77% | ||
1.21% | 388 M€ | +1.78% | - | |
1.07% | 35 M€ | +6.60% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-06 | 15.57 | -1.02% | 31 565 |
23-12-05 | 15.73 | +0.64% | 161,073 |
23-12-04 | 15.63 | -1.94% | 186,348 |
23-12-01 | 15.94 | +2.97% | 293,508 |
23-11-30 | 15.48 | +0.13% | 655,203 |
Real-time Irish Stock Exchange, December 05, 2023 at 11:55 am EST
More quotes
Glanbia plc specializes in the production and commercialization of dairy, nutritional and food products for the food and pharmaceutical industries. Net sales break down by product family as follows:
- nutritional and functional ingredients (71.2%): dairy, vegetable and functional proteins, nutrients (vitamins, trace elements, minerals, etc.), nutritional supplements for children, bioactive ingredients, etc. for dairy and non-dairy products (drinks, cereal bars, snacks, sauces, animal feed, etc.). The group is also developing a cheese production activity;
- performance nutrition products (28.8; world n°1): notably sports nutrition products (Optimum Nutrition, BSN, Isopure, thinkThin, Nutramino, ABB, Body & Fit and Amazing Grass brands).
Net sales are distributed geographically as follows: Ireland (0.2%), Europe (7.7%), United States (81.7%), North America (1.7%), Asia /Pacific (6.6%), Latin America (1 .3%) and others (0.8%).
Sector
Food Processing
Calendar
2024-02-27
- Q4 2023 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
Sell
Buy

Mean consensus
BUY
Number of Analysts
10
Last Close Price
15.73EUR
Average target price
16.42EUR
Spread / Average Target
+4.37%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.96% | 4 471 M $ | |
-14.74% | 23 468 M $ | |
-39.27% | 11 118 M $ | |
-12.64% | 6 759 M $ | |
-10.51% | 5 864 M $ | |
-17.86% | 5 779 M $ | |
+16.35% | 5 568 M $ | |
-34.49% | 5 044 M $ | |
-2.65% | 3 840 M $ | |
+18.80% | 2 904 M $ |